MDNAF Hisse Senedi Fiyat Grafiği
MDNAF Fiyat
Medicenna Therapeutics Corp
$0.26
1.25%
$0
Kapanışta: Aug 06, 16:00:00 GMT-4
$0.27
1.5%
$0
Sonrası Piyasa: Aug 06, 18:20:56 GMT-4
Geri
Medicenna Therapeutics Corp (MDNAF) Fiyat
Önemli İstatistikler
Önceki Kapanış
$0.2627
Açılış fiyatı
$0.266
Günün Aralığı
$0.266 - $0.27
52 haftalık aralık
$0.229 - $1.43
İşlem hacmi
78
Ort.Hacim
77.9K
Dividend yield
--
EPS (TTM)
-0.15
Piyasa Değeri
$24.9M
Medicenna Therapeutics Corp. nedir?
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2015-07-13. Its long-acting IL-2 Superkine, MDNA11, is a IL-2 with superior affinity toward CD122 (IL-2 receptor beta) and no CD25 (IL-2 receptor alpha) binding, thereby preferentially stimulating cancer-killing effector T cells and NK cells. Its IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials, including a Phase IIb trial for recurrent glioblastoma (GBM). Its early-stage high-affinity IL-2B biased IL-2/IL-15 Super-antagonists, from its MDNA209 platform, are being evaluated as potential therapies for autoimmune and graft-versus host diseases. Its early-stage BiSKITs (Bifunctional SuperKine ImmunoTherapies) and the T-MASK (Targeted Metalloprotease Activated SuperKine) programs are designed to enhance the ability of Superkines to treat immunologically cold tumors.
